Jean-Louis Mege

Jean-Louis Mege


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2011 in Current Opinion in Infectious Diseases
Verified
Journal Article
Closed access
JMJean-Louis Mege
Jean-Louis Mege
VMVikram Mehraj
Vikram Mehraj
CCChristian Capo
Christian Capo
Macrophages are the first line of defense against pathogens, and the mode of their activation will determine the success or failure of the host response to pathogen aggression. Based on limited numbers of markers, activated macrophages can be classified as classically activated (M1) macrophages that support microbicidal activity or alternatively activated (M2) macrophages that are not competent to eliminate pathogens. The development of high-throughput gene expression methods affords a reappraisal of the concept of macrophage activation in human infectious diseases. By combining microarray data and conventional approaches, it is becoming clear that the M1 polarization program is associated with gastrointestinal infections (e.g. typhoid fever and Helicobacter pylori gastritis) and active tuberculosis. An M2 signature is observed in lepromatous leprosy, Whipple's disease, and localized infections (keratitis, chronic rhinosinusitis). However, these findings could not be predicted from the analysis of the M1/M2 programs of macrophages stimulated in vitro. The reappraisal of macrophage polarization by high-throughput methods is critical to understanding the role of macrophage polarization in infectious diseases. Only the identification of individual profiles will support promising therapeutic approaches based on target determination.

25 January 2021 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
ABAsma Boumaza
Asma Boumaza
LGLaetitia Gay
Laetitia Gay
SMSoraya Mezouar
Soraya Mezouar
EBEloïne Bestion
Eloïne Bestion
ADAïssatou Bailo Diallo
Aïssatou Bailo Diallo
JMJean-Louis Mege
Jean-Louis Mege
Background: Coronavirus disease 2019 (COVID-19) clinical expression is pleiomorphic, severity is related to age and comorbidities such as diabetes and hypertension, and pathophysiology involves aberrant immune activation and lymphopenia. We wondered if the myeloid compartment was affected during COVID-19 and if monocytes and macrophages could be infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Methods: Monocytes and monocyte-derived macrophages (MDMs) from COVID-19 patients and controls were infected with SARS-CoV-2 and extensively investigated with immunofluorescence, viral RNA extraction and quantification, and total RNA extraction followed by reverse-transcription quantitative polymerase chain reaction using specific primers, supernatant cytokines (interleukins 6, 10, and 1β; interferon-β; transforming growth factor–β1, and tumor necrosis factor–α), and flow cytometry. The effect of M1- vs M2-type or no polarization prior to infection was assessed. Results: SARS-CoV-2 efficiently infected monocytes and MDMs, but their infection is abortive. Infection was associated with immunoregulatory cytokines secretion and the induction of a macrophagic specific transcriptional program characterized by the upregulation of M2-type molecules. In vitro polarization did not account for permissivity to SARS-CoV-2, since M1- and M2-type MDMs were similarly infected. In COVID-19 patients, monocytes exhibited lower counts affecting all subsets, decreased expression of HLA-DR, and increased expression of CD163, irrespective of severity. Conclusions: SARS-CoV-2 drives monocytes and macrophages to induce host immunoparalysis for the benefit of COVID-19 progression. SARS-CoV-2 infection of macrophages induces a specific M2 transcriptional program. In Covid-19 patients, monocyte subsets were decreased associated with up-expression of the immunoregulatory molecule CD163 suggesting that SARS-CoV-2 drives immune system for the benefit of Covid-19 disease progression.

17 May 2011 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
WTWiwit Tantibhedhyangkul
Wiwit Tantibhedhyangkul
TPThanavadee Prachason
Thanavadee Prachason
DWDuangdao Waywa
Duangdao Waywa
AFAdil El Filali
Adil El Filali
EGEric Ghigo
Eric Ghigo
JMJean-Louis Mege
Jean-Louis Mege
Orientia tsutsugamushi is the causal agent of scrub typhus, a public health problem in the Asia-Pacific region and a life-threatening disease. O. tsutsugamushi is an obligate intracellular bacterium that mainly infects endothelial cells. We demonstrated here that O. tsutsugamushi also replicated in monocytes isolated from healthy donors. In addition, O. tsutsugamushi altered the expression of more than 4,500 genes, as demonstrated by microarray analysis. The expression of type I interferon, interferon-stimulated genes and genes associated with the M1 polarization of macrophages was significantly upregulated. O. tsutsugamushi also induced the expression of apoptosis-related genes and promoted cell death in a small percentage of monocytes. Live organisms were indispensable to the type I interferon response and apoptosis and enhanced the expression of M1-associated cytokines. These data were related to the transcriptional changes detected in mononuclear cells isolated from patients with scrub typhus. Here, the microarray analyses revealed the upregulation of 613 genes, which included interferon-related genes, and some features of M1 polarization were observed in these patients, similar to what was observed in O. tsutsugamushi-stimulated monocytes in vitro. This is the first report demonstrating that monocytes are clearly polarized in vitro and ex vivo following exposure to O. tsutsugamushi. These results would improve our understanding of the pathogenesis of scrub typhus, during which interferon-mediated activation of monocytes and their subsequent polarization into an M1 phenotype appear critical. This study may give us a clue of new tools for the diagnosis of patients with scrub typhus. Scrub typhus, a life-threatening disease that occurs in the Asia-Pacific region, is a public health problem since a billion of people are at risk and one million new cases arise each year. Orientia tsutsugamushi, the causal agent of scrub typhus, is an obligate intracellular bacterium that mainly infects endothelial cells. We demonstrated here that O. tsutsugamushi grew in monocytes isolated from healthy donors and altered the expression of a large number of genes including interferon-related genes, genes associated with the M1 polarization of macrophages and apoptosis-related genes. Importantly, these data were related to the transcriptional changes detected in mononuclear cells isolated from patients with scrub typhus. Indeed, the microarray analyses revealed the upregulation of numerous genes, which included interferon-related genes, and some features of M1 polarization. This is the first report demonstrating that monocytes are clearly polarized in vitro and ex vivo following exposure to O. tsutsugamushi. These results improve our understanding of the pathogenesis of scrub typhus and may give us a clue of new tools for the diagnosis of patients with scrub typhus.

14 December 2010 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AAAmira Ben Amara
Amira Ben Amara
EGEric Ghigo
Eric Ghigo
YPYannick Le Priol
Yannick Le Priol
CLCatherine Lépolard
Catherine Lépolard
SSSuzana P. Salcedo
Suzana P. Salcedo
JMJean-Louis Mege
Jean-Louis Mege
Q fever is a zoonosis caused by Coxiella burnetii, an obligate intracellular bacterium typically found in myeloid cells. The infection is a source of severe obstetrical complications in humans and cattle and can undergo chronic evolution in a minority of pregnant women. Because C. burnetii is found in the placentas of aborted fetuses, we investigated the possibility that it could infect trophoblasts. Here, we show that C. burnetii infected and replicated in BeWo trophoblasts within phagolysosomes. Using pangenomic microarrays, we found that C. burnetii induced a specific transcriptomic program. This program was associated with the modulation of inflammatory responses that were shared with inflammatory agonists, such as TNF, and more specific responses involving genes related to pregnancy development, including EGR-1 and NDGR1. In addition, C. burnetii stimulated gene networks organized around the IL-6 and IL-13 pathways, which both modulate STAT3. Taken together, these results revealed that trophoblasts represent a protective niche for C. burnetii. The activation program induced by C. burnetii in trophoblasts may allow bacterial replication but seems unable to interfere with the development of normal pregnancy. Such pathophysiologocal processes should require the activation of immune placental cells associated with trophoblasts.

1 January 2021 in Placenta
Verified
Journal Article
Closed access
SMSoraya Mezouar
Soraya Mezouar
MKMaria Katsogiannou
Maria Katsogiannou
AAAmira Ben Amara
Amira Ben Amara
FBFlorence Bretelle
Florence Bretelle
JMJean-Louis Mege
Jean-Louis Mege

14 August 2019 in Frontiers in Immunology
Verified
Journal Article
Open access
SMSoraya Mezouar
Soraya Mezouar
IDIssa Diarra
Issa Diarra
JRJean Roudier
Jean Roudier
BDBenoit Desnues
Benoit Desnues
JMJean-Louis Mege
Jean-Louis Mege
More than half of tuberculosis cases in the world are due to resuscitation of dormant Mycobacterium tuberculosis (Mtb) sequestered into cell-derived structures called granulomas. It is fairly admitted that cytokines and more particularly Tumor Necrosis Factor (TNF)-α is critical in the control of Mtb infections and that anti-TNF-α drugs constitute one of the main risk factors for reactivation of latent Mtb infection. The aim of this study was to evaluate the role of etanercept, a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human p75 TNF receptor linked to the Fc portion of human IgG1, in an in vitro model of human tuberculous granuloma. We showed that etanercept slightly delayed the formation of granuloma and reduced the generation of multinuclear giant cells (MGCs). In addition, etanercept exacerbated the expression of M1 polarization genes but also induced interleukin (IL)-10 release. In addition, our results indicated that etanercept inhibited cell fusion in an IL-10-dependent manner. Moreover, adalimumab, a human monoclonal anti-TNF-α IgG1 inhibited MGC formation in granuloma, without altering IL-10 secretion and induced macrophage apoptosis. Taken together, our data provides new insights into the role of TNF-α blockers in MGCs formation and the impact of such immunomodulatory drugs on tuberculous granuloma maturation.